Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis

Journal of the Neurological Sciences

Volumn 137, Issue 2, 1996, Pages 89-96

  Wallström, Erik ^a   Diener, Per ^a   Ljungdahl, Åke ^a   Khademi, Mohsen ^a   Nilsson, Carl Gustaf ^b   Olsson, Tomas ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Clinical Research Center   (Sweden)

Author keywords

Experimental autoimmune encephalomyelitis (EAE); Interferon gamma (IFN ); Memantine; Myelin basic protein (MBP); N methyl D aspartate (NMDA) receptor; Neurological deficit

Indexed keywords

GAMMA INTERFERON; MEMANTINE; MYELIN BASIC PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030008498     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(95)00339-4     Document Type: Article

References (43)

1. Billiau, A., Heremans, H., Vandekerckhove, F., Dijkmans, R., Sobis, H., Meulepas, E. and Carton, H. (1988) Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J. Immunol., 140: 1506-1510.
2. Bormann, J. (1989) Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur. J. Pharmacol., 166: 591-592.
3. Brideau, R.J., Carter, P.B., McMaster, W.R., Mason, D.W. and Williams, A.F. (1980) Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur. J. Immunol., 10: 609-615.
4. Calne, D.B. (Ed.) (1994) Therapeutic manipulation of excitatory amino acid systems. Neurology, 44: Supplement 8.
5. Chao, C.C., Hu, S., Molitor, T.W., Shaskan, E.G. and Peterson, P.K. (1992) Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol., 149: 2736-2741.
6. Chen, H.S., Pellegrini, J.W., Aggarwal, S.K., Lei, S.Z., Warach, S., Jensen, F.E. and Lipton, S.A. (1992) Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J. Neurosci., 12: 4427-4436.
7. Cohen, R.A. and Fisher, M. (1989) Amantadine treatment of fatigue associated with multiple sclerosis. Arch. Neurol., 46: 676-680.
8. Collart, M.A., Belin, D., Vassalli, J.D., de Kossodo, S., and Vassalli, P. (1986) Gamma-interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin-1 and urokinase genes, which are controlled by short-lived repressers. J. Exp. Med., 164: 2113-2118.
9. Czerkinsky C., Andersson, G., Ekre, H.P., Nilsson, L.A., Klareskog, L. and Ouchterlony, Ö. (1988) Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon secreting cells. J. Immunol. Methods, 110: 29-36.
10. Duijvestijn, A.M., Schreiber, A.B. and Butcher, E.C. (1986) Interferon-gamma regulates an antigen specific for endothelial cells involved in lymphocyte traffic. Proc. Natl. Acad. Sci. USA, 83: 9114-9118.
11. Duong, T.T., St-Louis, J., Gilbert, J.J., Finkelman, F.D. and Strejan, G.H. (1992) Effect of anti-interferon-gamma and anti-interleukin 2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol., 36: 105-115.
12. Flanagan, E. M., Erickson, J. B., Viveros, O. H., Chang, S. Y., and Reinhard, J. F., Jr. (1995) Neurotoxin quinolinic acid is selectively elevated in spinal cords of rats with experimental allergic encephalomyelitis. J. Neurochem., 64: 1192-1196.
13. Fukumoto, T., McMaster, W.R. and Williams, A.F. (1982) Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus. Eur. J. Immunol., 12: 237-243.
14. Gasser, D.L., Goldner-Sauvé, A. and Hickey, W.F. (1990) Genetic control of resistance to clinical EAE accompanied by histological symptoms. Immunogenetics, 31: 377-382.
15. Gijbels, K., Galardy, R.E. and Steinman, L. (1994) Reversal of experimental autoimmune encephalomyelitis with a hydroxymate inhibitor of matrix metalloproteases. J. Clin. Invest., 94: 2177-2182.
16. Gilbert, J.J. and Sadler, M. (1983) Unsuspected multiple sclerosis. Arch. Neurol., 40: 533-536.
17. Heyes, M. P., Saito, K., Major, E. O., Milstien, S., Markey, S. P., and Vickers, J. H. (1993) A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxy-anthranilate. Brain, 116: 1425-1450.
18. Holmdahl, R., Moran, T. and Andersson, M. (1985) A rapid and efficient immunization protocol for production of monoclonal antibodies reactive with autoantigens. J. Immunol. Methods, 83: 379-384.
19. Jacobs, L., Kinkel, W.R., Polachini, I. and Kinkel, R.P. (1986) Correlations of nuclear magnetic resonance imaging, computerized tomography, and clinical profiles in multiple sclerosis. Neurology, 36: 27-34.
20. Keilhoff, G. and Wolf, G. (1992) Memantine prevents quinolinic acid-induced hippocampal damage. Eur. J. Pharmacol., 219: 451-454.
21. Komhuber, J., Bormann, J., Hübers, M., Rusche, K. and Riederer, P. (1991) Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study. Eur. J. Pharmacol., 206: 297-300.
22. Lipton, S.A. and Rosenberg P.A. (1993) Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med., 330: 613-622.
23. McMaster, W.R. and Williams, A.F. (1979) Identification of Ia glycoprotein in rat thymus and purification from rat spleen. Eur. J. Immunol., 9: 426-433.
24. Moreau, T., Wing, M., Waldman, H. and Compston, A. (1994) Cytokine release increases symptoms in patients with multiple sclerosis. Reported at 10th congress of the european committee for treatment and research in multiple sclerosis, Athens, 4-5 November 1994.
25. Mustafa, M.I., Diener, P., Höjeberg, B., Van der Meide, P. and Olsson, T. (1991) T cell immunity and Interferon-γ secretion during experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol., 31: 165-177.
26. Mustafa, M.I., Vingsbo, C., Olsson, T., Ljungdahl, Å., Höjeberg, B. and Holmdahl, R. (1993) The major histocompatibility complex influences myelin basic protein 63-88 induced T cell cytokine profile and experimental autoimmune encephalomyelitis. Eur. J. Immunol., 23: 3089-3095.
27. Offner, H., Hashim, G.A., Celnik, B., Galang, A., Li, X.B., Bums, F.R., Shen, N., Heber-Katz, E. and Vandenbark, A.A. (1989) T cell determinants of myelin basic protein include a unique encephalitogenic I-E restricted epitope for Lewis rats. J. Exp. Med., 170: 355-367.
28. Olsson, T., Zhi, W.W., Höjeberg, B., Kostulas, V., Jiang, Y.-P., Andersson, G., Ekre, H.-P. and Link, H. (1990) Autoreactive T lymphocytes in multiple sclerosis determined by antigen induced secretion of interferon-gamma. J. Clin. Invest., 86: 981-985.
29. Olsson, T. (1995) Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurology, 45, S 11-S 15.
30. Opdenakker, G. and van Damme, J. (1994) Cytokine regulated proteases in autoimmune diseases. Immunol. Today, 15: 103-107.
31. Panitch, H.S., Hirsch, R.L., Schindler, J. and Johnston, K.P. (1987) Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology, 37: 1097-1102.
32. Parsons, C.G., Gruner, R., Rozental, J., Millar, J. and Lodge, D. (1993) Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacol., 32; 1337-1350.
33. Piani D., Frei K., Do K.Q., Cuenod M., Fontana A. (1991) Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett., 133, 159-162.
34. Piani D., Spranger M., Frei K., Schaffner A., Fontana A. (1992) Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur. J. Immunol., 22, 2429-2436.
35. Rabey, J.M., Nissipeami, P. and Korczyn, A.D. (1992) Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease. J. Neural Transm. [P-D Sect.], 4: 277-282.
36. Rosenberg, G.A. and Appenzeller, O. (1988) Amantadine, fatigue, and multiple sclerosis. Arch. Neurol., 45: 1104-1106.
37. Sedgwick, J., Brostoff, S. and Mason, D. (1987) Experimental allergic encephalomyelitis in the absence of a classical delayed type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system. J. Exp. Med., 165: 1058-1075.
38. Seif el Nasr, M., Peruche, B., Roβberg, C., Mennel, H.-D. and Krieglstein, J. (1990) Neuroprotective effects of memantine demonstrated in vivo and in vitro. Eur. J. Pharmacol., 185: 19-24.
39. Skoskiewicz, M.J., Colvin, R.B., Schneeberger, E.E. and Russel, P.S. (1985) Widespread and selective induction of major histocompatibility complex determined antigens in vivo by gamma interferon. J. Exp. Med., 162: 1645-1664.
40. Spanagel R., Eilbacher B., Wilke R. (1994) Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat-a pharmacokinetic microdialysis study. Eur. J. Pharmacol., 262, 21-26.
41. Vandenbark, A.A., Offner, H., Reshef, T., Fritz, R., Chou, C.H. and Cohen, I.R. (1985) Specificity of T lymphocyte line for peptides of myelin basic protein. J. Immunol., 135: 229-233.
42. Voorthuis, J.A., Uitdenhaag, B.M., de Groot, C.J., Goede, P.M., van der Meide, P.H. and Dijkstra, C.D. (1990) Supression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rat. Clin. Exp. Immunol., 81: 183-188.
43. Williams, A.F., Galfre, G. and Milstein, C. (1977) Analysis of cell surfaces by xenogeneic myeloma hybrid antibodies: differentiation antigens of rat lymphocytes. Cell, 12: 663-673.